Masahiro Takeyama

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Topics

Venous Thromboembolism

Recombinant Human

High Throughput

Top Venues

International journal of hematology

Haemophilia : the official journal of the World Federation of Hemophilia

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Masahiro Takeyama, Shoko Furukawa, Kenichi Ogiwara, Shinobu Tamura, Hitoshi Ohno, Satoshi Higasa, Naruto Shimonishi, Yuto Nakajima, Tomoko Onishi, Keiji Nogami
Coagulation potentials of plasma-derived factors VIIa and X mixture (Byclot ® ) evaluated by global coagulation assay in patients with acquired haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Masahiro Takeyama, Naoki Matsumoto, Hiroto Abe, Suguru Harada, Kenichi Ogiwara, Shoko Furukawa, Naruto Shimonishi, Yuto Nakajima, Koji Yada, Tetsuhiro Soeda, Keiji Nogami
Coagulant potentials of emicizumab in the plasmas from infant and toddler patients with hemophilia A. Pediatric blood & cancer (2023)
Kuniyoshi Mizumachi, Yuto Nakajima, Naruto Shimonishi, Shoko Furukawa, Kenichi Ogiwara, Masahiro Takeyama, Keiji Nogami
Hybrid human-porcine factor VIII proteins partially escape the inhibitory effects of anti-factor VIII inhibitor alloantibodies having A2 or C2 domain specificity. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Yuto Nakajima, Kenichi Ogiwara, Naruto Shimonishi, Shoko Furukawa, Masahiro Takeyama, Keiji Nogami
Intra-articular haemorrhage caused by reduced recovery of PEGylated recombinant factor VIII due to an anti-PEG antibody developed after mRNA-1273 SARS-CoV-2 vaccination in haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Masahiro Takeyama, Shoko Furukawa, Kenichi Ogiwara, Keiji Nogami
First case report of hematidrosis complicated with type 1 von Willebrand disease. Pediatrics international : official journal of the Japan Pediatric Society 65 (1) (2023)
Fumitaka Shibasaki, Masahiro Takeyama, Kenichi Ogiwara, Shoko Furukawa, Yuto Nakajima, Naruto Shimonishi, Keiji Nogami
High levels of factor VIII activity in patients with acquired hemophilia A in remission are associated with unusually low coagulation potentials. International journal of hematology (2023)
Naruto Shimonishi, Kenichi Ogiwara, Junko Yoshida, Kyoji Horie, Yuto Nakajima, Shoko Furukawa, Masahiro Takeyama, Keiji Nogami
Impaired factor V-related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations. Blood advances (2023)
Masahiro Takeyama, Shoko Furukawa, Tomoko Onishi, Mariko Noguchi-Sasaki, Midori Shima, Keiji Nogami
Heterogeneous coagulant potential of emicizumab in neonatal factor VIII-deficient plasma. Pediatric blood & cancer 69 (7) (2022)
Tomoko Onishi, Naruto Shimonishi, Masahiro Takeyama, Shoko Furukawa, Kenichi Ogiwara, Yuto Nakajima, Kei Kasahara, Kenji Nishio, Kiyomi Yoshimoto, Satoki Inoue, Masahiko Kawaguchi, Hidetada Fukushima, Yoshihiko Saito, Hitoshi Yoshiji, Shigeo Muro, Kazuhiko Tsuruya, Sadanori Okada, Kazuma Sugie, Ryuji Kawaguchi, Toshiya Nishikubo, Masaharu Yamazaki, Yukio Oda, Toshiki Kawabe, Kengo Onishi, Tomohisa Nishio, Keiji Nogami
The balance of comprehensive coagulation and fibrinolytic potential is disrupted in patients with moderate to severe COVID-19. International journal of hematology 115 (6) (2022)
Hitomi Nishioka, Tomoko Onishi, Taito Kitano, Masahiro Takeyama, Natsuko Imakita, Kei Kasahara, Ryuji Kawaguchi, Jennifer Akiko Masaki, Keiji Nogami
A survey of healthcare workers' recommendations about human papillomavirus vaccination. Clinical and experimental vaccine research 11 (2) (2022)
Yuto Nakajima, Masahiro Takeyama, Akihisa Oda, Naruto Shimonishi, Keiji Nogami
Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential. Blood advances (2022)
Masahiro Takeyama, Shoko Furukawa, Koji Yada, Kenichi Ogiwara, Naruto Shimonishi, Yuto Nakajima, Kuniyoshi Mizumachi, Mariko Noguchi-Sasaki, Midori Shima, Keiji Nogami
Ex Vivo Prediction of Comprehensive Coagulation Potential Using Simulated Blood Concentrations of Emicizumab in Patients with Acquired Hemophilia A. Thrombosis and haemostasis 121 (10) (2021)
Masahiro Takeyama, Kana Sasai, Tomoko Matsumoto, Shoko Furukawa, Kenichi Ogiwara, Koji Yada, Tomoko Onishi, Midori Shima, Keiji Nogami
Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan. International journal of hematology (2021)
Satoshi Ochi, Masahiro Takeyama, Midori Shima, Keiji Nogami
Plasma-derived factors VIIa and X mixtures (Byclot®) significantly improve impairment of coagulant potential ex vivo in plasmas from acquired hemophilia A patients. International journal of hematology 111 (6) (2020)